Stay updated on Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial

Sign up to get notified when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Primary outcome maintenance phase wording updated to 'Baseline through Week 48' from 'post-randomization through Week 48'.
    Difference
    0.3%
    Check dated 2026-02-18T16:47:45.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The change is a minor revision update from v3.4.1 to v3.4.2; no substantive content changes are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:31:21.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision label v3.4.1 was added and the previous revision v3.4.0 was removed. This appears to be a cosmetic/versioning update that does not change study content or user-facing information on the page.
    Difference
    0.1%
    Check dated 2026-02-04T10:42:14.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added a Show glossary option and minor editorial updates to labeling and revision/version text (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:31:30.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.3.4 now displayed on the page (replacing v3.3.3). No changes to study content or navigation are apparent.
    Difference
    0.1%
    Check dated 2026-01-14T02:47:24.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Locations are consolidated under a single 'Locations' section listing the participating states, replacing the previous per-state location blocks. No changes to the actual sites, eligibility criteria, or study details.
    Difference
    1%
    Check dated 2025-12-23T20:19:49.000Z thumbnail image

Stay in the know with updates to Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.